Fulgent Pharma LLC.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of FID-022 in Participants With Advanced Solid Tumors (NCT06694480) | Fulgent Pharma LLC. | 2025-07-03 |
| FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma (NCT06332092) | Fulgent Pharma LLC. | 2024-04-10 |
Track Fulgent Pharma LLC. automatically
Every clearance here is in the API, with alerts when new ones post.